BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Soligenix 

29 Emmons Drive
Suite C-10
Princeton  New Jersey  08540  U.S.A.
Phone: 609-538-8200 Fax: 609-452-6467


SEARCH JOBS










 Company News
Soligenix (SNGX) Awarded National Institute of Allergy And Infectious Diseases (NIAID) Contract Valued Up To $24.7 Million 9/19/2014 6:25:08 AM
Soligenix (SNGX) Announces FDA Clearance Of Phase 3 Clinical Protocol Of SGX301 In Cutaneous T-Cell Lymphoma 9/17/2014 9:19:52 AM
Soligenix (SNGX) Announces Issuance Of US Patent for ThermoVax™ Technology 9/9/2014 7:59:13 AM
Soligenix (SNGX) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City 9/8/2014 8:44:09 AM
Soligenix (SNGX) Expands Pipeline With Acquisition Of Phase 3-Ready Oncology Clinical Program 9/5/2014 10:19:35 AM
Soligenix (SNGX) Announces Positive Survival Results With Heat Stable Ricin Toxin Vaccine 9/3/2014 3:42:14 PM
Soligenix (SNGX) Reports Second Quarter 2014 Financial Results, And Highlights Recent Accomplishments 8/11/2014 8:42:53 AM
Soligenix (SNGX) Advances Development Of A Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™ 8/7/2014 8:09:53 AM
Soligenix (SNGX) Advances Development Of A Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™ 8/7/2014 8:06:42 AM
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of OrbeShield™ In GI ARS 8/1/2014 7:14:57 AM
12345678910...